| 发明名称 |
Use of SNS-595 for treating leukemia |
| 摘要 |
The present invention relates to a compound which is (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for use in treating a hematologic cancer, wherein the compound is prepared to be administered in a dose of 60 mg/m 2 - 110 mg/m 2 . |
| 申请公布号 |
EP2295056(B1) |
申请公布日期 |
2016.01.06 |
| 申请号 |
EP20100177951 |
申请日期 |
2005.03.14 |
| 申请人 |
SUNESIS PHARMACEUTICALS, INC.;SUMITOMO DAINIPPON PHARMA CO., LTD. |
发明人 |
ADELMAN, DANIEL, C.;SILVERMAN, JEFFREY A.;MASARU, HIGAKI;SATOSHI, NAKAO |
| 分类号 |
A61K31/44;A61K9/00;A61K31/4375;A61K31/4745;A61K31/555;A61K31/7068;A61K38/18;A61K41/00;A61K45/06;A61K47/12;A61P35/00;A61P35/02;C07D471/04 |
主分类号 |
A61K31/44 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
